Crispr Therapeutics shares owned by Loomis, Sayles and
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Loomis, Sayles and
from 13F filings
Historical chart of Loomis, Sayles and investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Loomis, Sayles and
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $59M | 910k | 64.81 |
| 2025-06-30 | $42M | 857k | 48.64 |
| 2025-03-31 | $31M | 910k | 34.03 |
| 2024-12-31 | $36M | 911k | 39.36 |
| 2024-09-30 | $44M | 945k | 46.98 |
| 2024-06-30 | $54M | 1.0M | 54.01 |
| 2024-03-31 | $70M | 1.0M | 68.16 |
| 2023-09-30 | $50M | 1.1M | 45.39 |
| 2023-06-30 | $64M | 1.1M | 56.14 |
| 2023-03-31 | $52M | 1.2M | 45.23 |
| 2022-12-31 | $48M | 1.2M | 40.65 |
| 2022-09-30 | $81M | 1.2M | 65.35 |
| 2022-06-30 | $85M | 1.4M | 60.77 |
| 2022-03-31 | $81M | 1.3M | 62.77 |
| 2021-12-31 | $100M | 1.3M | 75.78 |
| 2021-09-30 | $104M | 926k | 111.93 |
| 2021-06-30 | $147M | 909k | 161.89 |